Neurodynamic Sequencing in Patients With Carpal Tunnel Syndrome

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05905107
Collaborator
(none)
56
1
2
6.8
8.2

Study Details

Study Description

Brief Summary

Carpal tunnel syndrome is a compressive neuropathy of median nerve in the fascial tunnel at wrist which causes pain, numbness ,and tingling in the extremities. Common treatment options used in the treatment of carpal tunnel syndrome are conservative and surgical treatment option is better, this question is still a topic requiring more and more clinical trials. Neuromobilisation described by Butler is one of the treatment options which are used in the treatment of carpal tunnel syndrome in conjunction with other conservative measures.

This proposed study will find out the effectiveness of Neuromobilisation in treatment of carpal tunnel syndrome. As there is very little evidence available which Neuromobilisation technique is effective and what are the types of patients which can get benefit from this technique. This study will find out the effect of Neuromobilisation in patients suffering from carpal tunnel syndrome of non traumatic origin. This is a randomized clinical trial. Target population is patients suffering from carpal tunnel syndrome of non-traumatic origin. Data will be collected from District Headquarter Hospital Faisalabad. This study will include 56 participants according to the selection criteria. The participants will be randomly divided into two groups through sealed opaque envelop method.

Group A will recruit 28 patients which fulfill the inclusion criteria. These patients will be treated by nerve sequencing proximal to distal in 3 sets of 15 repetitions in one session on alternate days for 4 weeks. Group B will recruit 28 patients which fulfill the inclusion criteria. These patients will be treated by nerve sequencing distal to proximal in 3 sets of 10 repetitions in one session for 4 weeks. The Statistical analysis will be performed through SPSS Software 21.

Condition or Disease Intervention/Treatment Phase
  • Other: Neurodynamic Slider Technique from Proximal to Distal
  • Other: Neurodynamic Slider Technique from Distal to Proximal
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Neurodynamic Sequencing on Pain, Wrist Range of Movement and Functional Disability in Patients With Carpal Tunnel Syndrome
Actual Study Start Date :
Jan 4, 2023
Anticipated Primary Completion Date :
Jul 15, 2023
Anticipated Study Completion Date :
Jul 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Interventional Group A

These patients will be treated by nerve sequencing proximal to distal in 3 sets of 15 repetitions in one session on alternate days for 4 weeks. For this, participants will be given a comfortable supine lying position. ULTT method will be implemented to the ipsilateral upper limb given in the table below

Other: Neurodynamic Slider Technique from Proximal to Distal
Neurodynamic Slider Technique from proximal to distal at wrist, elbow and neck

Active Comparator: Interventional Group B

These patients will be treated by nerve sequencing distal to proximal in 3 sets of 10 repetitions in one session for 4 weeks. For this, participants will be given a comfortable supine lying position. ULTT method will be implemented to the ipsilateral upper limb

Other: Neurodynamic Slider Technique from Distal to Proximal
Neurodynamic Slider Technique from proximal to distal at wrist, elbow and neck

Outcome Measures

Primary Outcome Measures

  1. Pain at wrist joint [4 weeks]

    Pain will be assessed by using Numerical Pain Rating Scale Pain will be assessed by using Numerical Pain Rating Scale

  2. Wrist Range of Movement at wrist joint [4 weeks]

    Range of motion will be assessed by using Goniometer

  3. Functional Ability at wrist joint [4 weeks]

    Functional Ability will be assessed by using Boston Carpal tunnel syndrome

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients positive for provocative test ( Phalen's test, Wrist decompression test and tinnel test).
Exclusion Criteria:
  • Inflammation around the wrist

  • Tumor around the wrist

  • Rheumatoid Arthritis

  • Osteoporosis

  • Joint Hypermobility

Contacts and Locations

Locations

Site City State Country Postal Code
1 District Headquarters Hospital Faisalābad Punjab Pakistan 38000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Sahreen Anwar, Ph.D, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05905107
Other Study ID Numbers:
  • REC_FSD_00325
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023